Member Info for EmeraldCarrots

Whos cancer has changed to a type that their drug is not even designed to work on since the original biopsy months previous. How the market does not understand this I find totall incredible and it shows just how mad the market is.

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

All IMHO.

Up 13.79%.

does not want candidates who's cancer has changed since the original biopsy on the removed solid tumor to HER2 negative. Pretty obvious is it not? The RNS from 2nd Jan:-

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

Using Angle's Parsortix system shortly before the trial starts those candidates can be weeded out, can they not, thus saving Eisai a fortune. Same for any other Co. doing a drug trial invelving the HER2 protein. Also the HER2 status can be monitored during and after the trial.

All IMHO.

Up 6.82%.

Hefty trades this am.

Up 6.82%

Up 4.55%

Cancer drug trial participants shortly before a trial begins won't give the correct up to date HER2 status of the cancer in question. Note the circulating tumour cells (CTC's) would have come from the tumour within the last few hours. The original HER2 status being obtained from testing the original tumour weeks if not months previously. That in itself is worth tens of millions, possibly hundreds of millions. Or maybe I'm mad? Or Eisai Inc. have actually listened to Angle and placed a fantastic order (for them) that the rest of the industry will eventually (yawn) realise was a game changer (when they wake up). They all seem to be asleep, well, other than Astrazeneca I suppose.

All IMHO.

Moves like quicksilver.

Sp keeps pushing up to around 2.9p then falling back.

All IMHO.

Catch this one right and it could be a traders dream. Unfortunately I did not, but live and learn. I need about 3p to get back in the swing of things but that is quite possible over the coming days.

All IMHO.

Waiting.

Anyone got an update?

6p is a long way off at the moment as the sp is 2.6p. That is 2.3 times the current price. FDA approval for the Genedrive MT-RNR1 at the moment is the only thing I would be fairly confident would achieve this. 3 to 6 months from application. I see 3p no big problem in the next few weeks though even without any news.

All IMHO.

Should be glad.

Boing!

JohnTerrySlipped.

"Proving difficult to buy. News coming around the bend?"

==============================

Their inability so far to follow up the Eisai and Astrazeneca deals IS driving me around the bend.

Still not having landed another contract similar to the Eisai or Astrazeneca ones. They need to have a very serious review to see what the problem is. How on earth can you sign up Eisai and Artazeneca then not follow on with something similar in the next 6 months? What are their sales people doing? It is quite astonishing.

All IMHO.

UP 10.2%

8.16% up now.

Which is rather pleasing.

Hello.